1 - 10 of 331
The EVAN Foundation Pledges to Continue its Support of the Evan Lindberg Neuroblastoma Research Scholars Program at CHOP
Published on Mar 29, 2021 in Press Releases
The Scholars Program supports exceptional early-career scientists at CHOP who are dedicated to finding a cure for neuroblastoma.
Published on Mar 26, 2021 in Press Releases
CHOP was the lead enrolling site in the clinical trial that led to the approval of the Harmony™ Transcatheter Pulmonary Valve (TPV).
Published on Mar 23, 2021 in Press Releases
The supplement also proved effective at preventing the formation of amyloid proteins, which may lead to treatments for certain forms of dementia.
The team analyzed more than 400 individuals with SCN2A-related disorder, which has been linked to a variety of neurodevelopmental disorders.
Large study provides head impact sensor analysis across four HS varsity sports and both genders, a first for basketball and field hockey.
Published on Mar 16, 2021 in Press Releases
The grant funds the development of a drug that targets a transcription factor that drives aggressive pediatric cancers.
Published on Mar 12, 2021 in Press Releases
The researchers determined what happens at a cellular level as the lung alveolus forms and allows newborns to breathe air.
Published on Mar 11, 2021 in Press Releases
The findings help to identify possible targets for future therapies for ribosomopathies, childhood disorders that lead to bone marrow failure.
Published on Mar 9, 2021 in Press Releases
The researchers described how a single nucleotide change can have large downstream effects, publishing their findings in Genome Biology.
Published on Mar 5, 2021 in Press Releases
A new study shows blinatumomab is less toxic and as good or better than chemotherapy for high-risk relapsed B-ALL.